Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...
IPO - Read IPO Review and Analysis on The Economic Times. Find out IPO Issue Price, Subscription Dates and Status, IPO Listing Date and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback